van Griensven, J; Edwards, T; de Lamballerie, X; Semple, MG; Gallian, P; Baize, S; Horby, PW; Raoul, H; Magassouba, N; Antierens, A; +53 more... Lomas, C; Faye, O; Sall, AA; Fransen, K; Buyze, J; Ravinetto, R; Tiberghien, P; Claeys, Y; De Crop, M; Lynen, L; Bah, EI; Smith, PG; Delamou, A; De Weggheleire, A; Haba, N; Ebola-Tx Consortium; , COLLABORATORS; Camara, BS; Olivier, KJ; Ballo, Y; Sakoba, K; Konde, K; Colebunders, R; Muyembe, JJ; Menten, J; Alexander, N; Van Den Broecke, S; Custers, A; Temmerman, S; Ingelbeen, B; Arango, D; Crucitti, T; Jacobs, J; Cuylaerts, V; Vermoessen, T; Ronse, M; Saez, AM; Bigey, F; Briki, M; Chambe, E; Chavarin, P; Devillers, M; Gauthier, M; Guillard, A; Isola, H; Jacquot, C; Lardin, B; Lavedrine, V; Lazaygues, C; Van de Kerckhove, P; Gueguen, M; Jonckheere, S; Andersen, HB; (2016) Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea. The New England journal of medicine, 374 (1). pp. 33-42. ISSN 0028-4793 DOI: https://doi.org/10.1056/NEJMoa1511812

Bonnet, M; Roper, C; Felix, M; Coulibaly, L; Kankolongo, GM; Guthmann, JP; (2007) Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zerekore. Malaria journal, 6. ISSN 1475-2875 DOI: https://doi.org/10.1186/1475-2875-6-54

Turner, PC; Sylla, A; Kuang, SY; Marchant, CL; Diallo, MS; Hall, AJ; Groopman, JD; Wild, CP; (2005) Absence of TP53 codon 249 mutations in young Guinean children with high aflatoxin exposure. Cancer epidemiology, biomarkers & prevention, 14 (8). pp. 2053-2055. ISSN 1055-9965 DOI: https://doi.org/10.1158/1055-9965.EPI-04-0923 Full text not available from this repository.